Brandon Couillard
Stock Analyst at Wells Fargo
(3.38)
# 963
Out of 5,241 analysts
178
Total ratings
44.79%
Success rate
5.27%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Equal-Weight | $355 → $370 | $333.26 | +11.02% | 9 | May 14, 2026 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $675 → $615 | $447.81 | +37.34% | 9 | May 8, 2026 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Overweight | $4.5 → $5.5 | $4.22 | +30.33% | 3 | May 8, 2026 | |
| NTRA Natera | Maintains: Equal-Weight | $215 → $220 | $196.04 | +12.22% | 5 | May 8, 2026 | |
| TECH Bio-Techne | Maintains: Overweight | $76 → $62 | $45.47 | +36.35% | 4 | May 7, 2026 | |
| MYGN Myriad Genetics | Maintains: Equal-Weight | $6 → $5.5 | $3.55 | +54.93% | 5 | May 6, 2026 | |
| WGS GeneDx Holdings | Maintains: Overweight | $155 → $75 | $42.13 | +78.02% | 8 | May 5, 2026 | |
| BIO Bio-Rad Laboratories | Maintains: Equal-Weight | $320 → $290 | $281.05 | +3.18% | 14 | May 1, 2026 | |
| BIO.B Bio-Rad Laboratories | Maintains: Equal-Weight | $320 → $290 | $291.00 | -0.34% | 14 | May 1, 2026 | |
| DHR Danaher | Maintains: Equal-Weight | $240 → $212 | $167.04 | +26.92% | 6 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $110 → $90 | $82.29 | +9.37% | 2 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $175 → $165 | $110.57 | +49.23% | 26 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $190 → $180 | $108.52 | +65.87% | 4 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $21 | $20.53 | +2.29% | 5 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $120 → $125 | $98.19 | +27.30% | 3 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $16 → $14 | $7.64 | +83.25% | 6 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $83 → $94 | $99.83 | -5.84% | 5 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $107 → $110 | $95.87 | +14.74% | 4 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $1,400 → $1,450 | $1,050.77 | +37.99% | 7 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $48 → $55 | $42.59 | +29.15% | 7 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $260 | $155.16 | +67.57% | 11 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $77 → $80 | $72.92 | +9.71% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $23.05 | -0.22% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $2.38 | +446.22% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.08 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $2.46 | +347.15% | 2 | Oct 13, 2017 |
Waters
May 14, 2026
Maintains: Equal-Weight
Price Target: $355 → $370
Current: $333.26
Upside: +11.02%
Thermo Fisher Scientific
May 8, 2026
Maintains: Overweight
Price Target: $675 → $615
Current: $447.81
Upside: +37.34%
Maravai LifeSciences Holdings
May 8, 2026
Maintains: Overweight
Price Target: $4.5 → $5.5
Current: $4.22
Upside: +30.33%
Natera
May 8, 2026
Maintains: Equal-Weight
Price Target: $215 → $220
Current: $196.04
Upside: +12.22%
Bio-Techne
May 7, 2026
Maintains: Overweight
Price Target: $76 → $62
Current: $45.47
Upside: +36.35%
Myriad Genetics
May 6, 2026
Maintains: Equal-Weight
Price Target: $6 → $5.5
Current: $3.55
Upside: +54.93%
GeneDx Holdings
May 5, 2026
Maintains: Overweight
Price Target: $155 → $75
Current: $42.13
Upside: +78.02%
Bio-Rad Laboratories
May 1, 2026
Maintains: Equal-Weight
Price Target: $320 → $290
Current: $281.05
Upside: +3.18%
Bio-Rad Laboratories
May 1, 2026
Maintains: Equal-Weight
Price Target: $320 → $290
Current: $291.00
Upside: -0.34%
Danaher
Apr 22, 2026
Maintains: Equal-Weight
Price Target: $240 → $212
Current: $167.04
Upside: +26.92%
Mar 5, 2026
Maintains: Equal-Weight
Price Target: $110 → $90
Current: $82.29
Upside: +9.37%
Feb 26, 2026
Maintains: Overweight
Price Target: $175 → $165
Current: $110.57
Upside: +49.23%
Feb 25, 2026
Maintains: Overweight
Price Target: $190 → $180
Current: $108.52
Upside: +65.87%
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $18 → $21
Current: $20.53
Upside: +2.29%
Feb 20, 2026
Maintains: Overweight
Price Target: $120 → $125
Current: $98.19
Upside: +27.30%
Feb 13, 2026
Maintains: Overweight
Price Target: $16 → $14
Current: $7.64
Upside: +83.25%
Feb 4, 2026
Maintains: Equal-Weight
Price Target: $83 → $94
Current: $99.83
Upside: -5.84%
Feb 3, 2026
Maintains: Equal-Weight
Price Target: $107 → $110
Current: $95.87
Upside: +14.74%
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $1,400 → $1,450
Current: $1,050.77
Upside: +37.99%
Dec 15, 2025
Maintains: Overweight
Price Target: $48 → $55
Current: $42.59
Upside: +29.15%
Jan 23, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $155.16
Upside: +67.57%
Jan 23, 2025
Maintains: Hold
Price Target: $77 → $80
Current: $72.92
Upside: +9.71%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $23.05
Upside: -0.22%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $2.38
Upside: +446.22%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $3.08
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $2.46
Upside: +347.15%